“Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS)”, Braz. J. Pharm. Sci., vol. 58, Dec. 2022, doi: 10.1590/s2175-97902022e20400.